Amgen Inc. is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology. Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people’s lives. A biotechnology pioneer, Amgen has grown to be one of the world’s leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential. Amgen was incorporated in California in 1980 and became a Delaware corporation in 1987. We have a presence in approximately 100 countries worldwide. Amgen operates in one business segment: human therapeutics.

NewsInvestor RelationsDividends

Score25,5
Updated10/27/2020FCF CAGR 5Y-1,36%
SectorHealthcareDebt Coverage7,65
CodeNASDAQ:AMGNBVPS CAGR 5Y-15,22%
Moat4D/E Avg 5Y1,90
Cust. Base2EPS/Div. Avg 5Y2,12
Beta0,74FCF/Div. Avg 5Y3,19
Div. Streak9R&D Avg 5Y16,89%
Div. CAGR 5Y12,91%ROA Avg 5Y9,45%
Payout Avg 5Y66,36%ROE Avg 5Y40,58%
EPS CAGR 5Y7,29%ROIC Avg 5Y12,77%
(mil.)20152016201720182019
Revenues21 66222 99122 84923 74723 362
Earnings6 9397 7221 9798 3947 482
Equity28 08329 87525 24112 5009 673
Total Debt31 55634 59635 34233 92929 903
Earnings/Share9,0610,242,6912,6212,88
Dividends/Share3,164,004,605,285,80
FCF/Share12,1513,0314,5616,7714,43
ROA9,67%9,95%2,48%12,64%12,53%
ROE24,71%25,85%7,84%67,15%77,35%
ROIC11,64%11,98%3,27%18,08%18,91%
FCF/Dividends3,843,263,163,182,49
EPS/Dividends2,872,560,582,392,22
Book Value/Share37,3440,4734,9519,8516,36
Debt/Share41,9646,8748,9453,8950,56
Payout Ratio %34,88%39,06%171,00%41,84%45,03%

See the Guidelines for more explanations.

See more Companies.


© 2020 - Cyceon SARL, All rights reserved. Data is obtained from sources believed to be reliable and is provided without warranties of any kind. The publisher is not responsible for any errors or omissions herein. This publication does not constitute investment advice and is only for user's own, non-commercial, internal use. No part of it may be reproduced, resold, stored or transmitted in any printed, electronic or other form, or used for generating or marketing any printed or electronic publication, service or product.